Biotricity Inc Total Assets
Biotricity Inc total assets. Based on the latest financial reports, Biotricity Inc (BTCY) holds total assets worth $6.32 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Biotricity Inc stock valuation for the company's overall valuation and market capitalisation.
Total Assets of Biotricity Inc (2014–2025)
Total assets of Biotricity Inc from 2014 to 2025. This chart illustrates how Biotricity Inc's total assets have evolved over time, based on quarterly financial data. See today's stock price for Biotricity Inc for real-time trading data and today's change.
Biotricity Inc - Asset Composition Analysis
Biotricity Inc Total Assets Breakdown (March 2025)
Biotricity Inc total assets breakdown as of March 2025. Biotricity Inc's total assets of $6.32 Million consist of 82.2% current assets and 17.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 6.5% |
| Accounts Receivable | $2.72 Million | 48.2% |
| Inventory | $1.56 Million | 27.6% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2014–2025)
This chart illustrates how Biotricity Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Biotricity Inc (BTCY) liquidity to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Biotricity Inc's current assets represent 82.2% of total assets in 2025, a decrease from 100.0% in 2014.
- Cash Position: Cash and equivalents constituted 6.5% of total assets in 2025, down from 86.5% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2014.
- Asset Diversification: The largest asset category is accounts receivable at 48.2% of total assets.
Biotricity Inc Competitors by Total Assets
Key competitors of Biotricity Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
BMC Medical Co. Ltd. A
SHE:301367
|
China | CN¥3.59 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Hironic Co. Ltd
KQ:149980
|
Korea | ₩80.01 Billion |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
Biotricity Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.23 | 0.19 | 0.59 |
| Quick Ratio | 0.14 | 0.10 | 0.57 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-18.08 Million | $-17.42 Million | $-3.50 Million |
Biotricity Inc - Advanced Valuation Insights
This section examines the relationship between Biotricity Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 33.02 |
| Latest Market Cap to Assets Ratio | 0.51 |
| Asset Growth Rate (YoY) | -5.1% |
| Total Assets | $5.64 Million |
| Market Capitalization | $2.87 Million USD |
Valuation Analysis
Below Book Valuation: The market values Biotricity Inc's assets below their book value (0.51x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Biotricity Inc's assets decreased by 5.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Biotricity Inc (2014–2025)
The table below shows the annual total assets of Biotricity Inc from 2014 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | $5.64 Million | -5.08% |
| 2024-03-31 | $5.94 Million | -8.72% |
| 2023-03-31 | $6.51 Million | -60.96% |
| 2022-03-31 | $16.68 Million | +275.80% |
| 2021-03-31 | $4.44 Million | +121.41% |
| 2020-03-31 | $2.00 Million | +308.51% |
| 2019-03-31 | $490.66K | -47.21% |
| 2018-03-31 | $929.43K | +96.28% |
| 2017-03-31 | $473.51K | -8.78% |
| 2016-03-31 | $519.09K | -0.17% |
| 2015-03-31 | $520.00K | 0.00% |
| 2014-03-31 | $520.00K | -- |
About Biotricity Inc
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux and Biocore Pro, an integrated ECG device and software that utilizes … Read more